Revenue | ₹57.76Cr |
Net Profits | ₹0.21Cr |
Net Profit Margins | 0.36% |
Balaxi Pharmaceuticals Ltd’s revenue fell -21.17% since last year same period to ₹57.76Cr in the Q2 2025-2026. On a quarterly growth basis, Balaxi Pharmaceuticals Ltd has generated -16.25% fall in its revenue since last 3-months.
Balaxi Pharmaceuticals Ltd’s net profit fell -95.42% since last year same period to ₹0.21Cr in the Q2 2025-2026. On a quarterly growth basis, Balaxi Pharmaceuticals Ltd has generated -27.59% fall in its net profits since last 3-months.
Balaxi Pharmaceuticals Ltd’s net profit margin fell -94.2% since last year same period to 0.36% in the Q2 2025-2026. On a quarterly growth basis, Balaxi Pharmaceuticals Ltd has generated -13.53% fall in its net profit margins since last 3-months.
The revenue for Balaxi Pharmaceuticals Ltd in the Q2 results 2025 was ₹57.76Cr.
The net profit for Balaxi Pharmaceuticals Ltd in the Q2 results 2025 was ₹0.21Cr.
The net profit margin for Balaxi Pharmaceuticals Ltd in the Q2 results 2025 was 0.36%.
The revenue for Balaxi Pharmaceuticals Ltd in the Q2 results 2024 was ₹73.27Cr.
The net profit for Balaxi Pharmaceuticals Ltd in the Q2 results 2024 was ₹4.59Cr.
The net profit margin for Balaxi Pharmaceuticals Ltd in the Q2 results 2024 was 6.26%.